Skip to content

Apotheek De Geyter

Active
Public limited companyfounded 1985active for 41 yearsHoogstraat 10, 9620 Zottegem, BelgiumKBO/BCE: BE 0427.043.290
Summary

Apotheek De Geyter has been active since 1985 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €137,221 and a net result of €73,700. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 45% of 12,686 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
Apotheek De GeyterActiveChecked score 87/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €670,000turnover 2025, estimated
Staff
1.1 FTE
Equity
€137,221
Profit
€73,700
Turnover estimated from the gross margin
Financial health
87 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Parent
GeMu Farma · 100%
  • GeMu FarmaDirector · permanent representative Veerle De Geyter
2025 accounts 36 days early1 of 11 deeds summarised
Why 87raises riskSector: Retail trade (NACE 47)Size: 1.1 FTE, total assets €432,080lowers riskFounded in 1985Legal form: public limited companyShow the evidence

Checked score

Score 2025
87 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 53% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 57+1
equity 31.8% of total assets
Liquidity 36+2
short-term debt 43.7% · cash 5.4%
Profitability 90+2
return on assets 17.1%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,248 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.3%▲ +0.1 percentage points vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025highest value 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.2%▼ -0.1 percentage points vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025lowest value 12-2025: 0.2%● unchanged vs 11-2025lowest value 01-2026: 0.3%▲ +0.1 percentage points vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.2%▼ -0.1 percentage points vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.16, compared with 2.1 in 2024, above the usual 1.5; short-term debt: 43.7% and cash: 5.4% of total assets), but 68.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 47% on solvency, 33% on liquidity, 85% on profitability and 45% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1985
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Legal form: public limited company
KBO
raises risk · Size: 1.1 FTE, total assets €432,080
Companies of this size fail more often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year €137,221
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 25-03-2026, 36 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
36 days early
2024
40 days early
2023
40 days early
2022
2 days early
2021
31 days early
2020
32 days early
2019
15 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 28 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 25 March (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end28-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Reappointment: GeMu Farma (director)Permanent representative: Veerle De Geyter…
  2. Annual accounts filedfinancial year 2025 · abbreviated…
  3. Highest result from 2019 to 2025net €73,700 ▲10.9%

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Controlled by GeMu Farma 100% View
  • New directorlatest change 06-03-2026 · 1 in office 1 joined View
  • Positive: 5 profitable years in a rowprofit 2025: €73,700 5 years View

By topic

Financials

Financial year
2025
Total assets
€432,080
Profit
€73,700
Solvency
31.8%
Total assets▼ 1.1%
Net result
20192025
Go to Financials

Timeline

Events
46
Since
1986
Next accounts
by 30-04-2027
  1. 21-03-2025Annual accounts filed
  2. 21-03-2024Annual accounts filed
  3. 30-09-2023Equity above €100,000
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
29-03-1985
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Apotheek De Geyter

What is the company number of Apotheek De Geyter?
0427.043.290. In Belgium the VAT number is the company number with BE in front: BE 0427.043.290.
Where is Apotheek De Geyter based?
The registered office is at Hoogstraat 10, 9620 Zottegem.Company details
What does Apotheek De Geyter do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek De Geyter?
Public limited company (NV).
When was Apotheek De Geyter founded?
On 29-03-1985.
Is Apotheek De Geyter still active?
Yes, Apotheek De Geyter is an active enterprise in the KBO register.
How many employees does Apotheek De Geyter have?
On average 1.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek De Geyter?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Apotheek De Geyter profitable?
In financial year 2025, Apotheek De Geyter made a profit of €73,700.
Where can I find the annual accounts of Apotheek De Geyter?
Apotheek De Geyter filed 41 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek De Geyter due?
By 30-04-2027, for financial year 2026.Timeline

Companies related to Apotheek De Geyter

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure